Carlos Campoy
2020
In 2020, Carlos Campoy earned a total compensation of $1.7M as Senior Vice President, Chief Financial Officer at CytomX Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $144,723 |
|---|---|
| Option Awards | $972,860 |
| Salary | $360,052 |
| Other | $264,004 |
| Total | $1,741,639 |
Campoy received $972.9K in option awards, accounting for 56% of the total pay in 2020.
Campoy also received $144.7K in non-equity incentive plan, $360.1K in salary and $264K in other compensation.
Rankings
In 2020, Carlos Campoy's compensation ranked 6,162nd out of 13,090 executives tracked by ExecPay. In other words, Campoy earned more than 52.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,162 out of 13,090 | 53rd |
Division Manufacturing | 2,545 out of 5,624 | 55th |
Major group Chemicals And Allied Products | 1,024 out of 2,257 | 55th |
Industry group Drugs | 883 out of 1,957 | 55th |
Industry Pharmaceutical Preparations | 658 out of 1,462 | 55th |
Source: SEC filing on April 27, 2022.
Campoy's colleagues
We found four more compensation records of executives who worked with Carlos Campoy at CytomX Therapeutics in 2020.